Cold compress

OTHER5 trials

Sponsors

Aston University, Kythera Biopharmaceuticals, Virginia Commonwealth University, AbbVie, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

AsthenopiaCold CompressDry EyeGlioblastoma MultiformeHypersensitivityIntrauterine DeviceModerate or Severe Submental Fullness

Phase 3

Patient Experience Study of Deoxycholic Acid Injection

CompletedNCT02007434

Kythera BiopharmaceuticalsModerate or Severe Submental Fullness

Start: 2013-12-31End: 2014-06-30Updated: 2015-07-28

UNITE Study: Understanding New Interventions With GBM ThErapy

TerminatedNCT03419403

AbbVieGlioblastoma Multiforme

Start: 2018-07-30End: 2020-03-03Updated: 2021-04-14

Phase 4

Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis

CompletedNCT01569191

Aston UniversityHypersensitivity

Start: 2012-03-31End: 2013-02-28Updated: 2018-02-05

Unknown Phase

Cold Compress for Pain Associated With Intrauterine Device Insertion

CompletedNCT02898831

Virginia Commonwealth UniversityCold Compress, Intrauterine Device

Start: 2016-04-30End: 2017-12-31Updated: 2019-03-18

Dry Eye and Asthenopia Treatment Effect Evaluation.

CompletedNCT06763822

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAsthenopia, Dry Eye

Start: 2024-06-16End: 2024-10-24Updated: 2025-01-08

Related Papers

A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin

Ophthalmic Research2023-01-014 citations

ACTR-21. MANAGEMENT OF OCULAR SIDE EFFECTS IN PATIENTS WITH EGFR-AMPLIFIED GLIOBLASTOMA RECEIVING DEPATUXIZUMAB MAFODOTIN

Neuro-Oncology2018-11-01

Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat.

2016-11-0120 citations